Dr Thira Unveils Johnson & Johnson Vaccine Provides 85% Prevention of Severe COVID Illness
Today (30 Jan ’64), MD. Teeraworathanarat, Faculty of Medicine Chulalongkorn University Post on Facebook about the coronavirus situation –19 Around the world By mentioning the vaccine news, Johnson & Johnson stated that
“If compared with the middle of the year 2020 Will find that the average number of infections per day is about 3 And there were more severe and critical cases per day than before 2 Times with the average number of deaths per day than before 3 As much
The number of infections Number of severe cases and crises And the number of deaths each day is increasing. It was found that it grew faster and clear since November 2563 Since
Noteworthy is The increasing number of severe cases and crises are in proportion to the increased number of deaths. Relevant factors would not be the only number of infections that increased. May be related to the variation of the species of the outbreak. Which if determined according to the time period It was during the outbreak of new species. As previously known
Therefore, we can understand the concern of international medical community following the results of different vaccines. That it will still work with new strains such as the UK, South Africa, etc.
With current information The vaccine appears to be working for the UK strains that are now spreading out across the world. But with the South African species Seems to be somewhat less effective. But more studies are still needed.
The results of the third phase of another vaccine have recently been published, the company. Johnson & Johnson America’s
Is a type of vaccine Adenovirus vector Similar to that of Astrazeneca/Oxford
Which is the vaccine used Adenovirus-26 It carries the part of the gene that determines the protein thorn part of the coronavirus –19 To stimulate the body to build immunity in the blood Or antibodies coming up while of Astrazeneca/Oxford use Chimpanzee Adenovirus
Johnson & Johnson Conducting research on a number of volunteers 43,783 People both in America, Latin America and South Africa.
The results showed that it was able to prevent infections with moderate to severe symptoms. 66% Evaluate at 28 Days after vaccination (Overview of all research countries) classified as 72% In america 66% In Latin America and 57% In south africa
However, if analyzing only severe illness Can be prevented 85%
The advantages of the vaccine Johnson & Johnson Is to inject only one needle And the storage of vaccines can be stored in a normal refrigerator. Different from vaccines mRNA That must be stored in extremely cold temperatures, which can be a practical problem in countries without a cold chain Good enough
Expected Johnson & Johnson Will be filing for approval to the relevant authorities in February. Considering the use of vaccines to prevent various diseases, the principle of deciding whether to inject anything or not Need to consider the necessity Detailed information pertaining to that vaccine study Properties of prevention, injection method, number of times, time to injections Including any side effects or adverse reactions that may occur.
People should inquire about medical personnel thoroughly. And need to tell in detail about the underlying disease that you have And a history of drug allergies, food allergies or various allergic reactions In the past that used to be Will help each other be careful And make the right decisions After vaccination, at least wait for symptoms 30 minute”
Catch up on the news here
website: www.TNNThailand.com
facebook : TNNThailand
facebook live : TNN Live
twitter : @TNNThailand
Line : @TNNONLINE
Youtube Official : TNNThailand
Instagram : @tnn_online
TICKETS: @tnnonline
–
